J. A. Al-Maghrabi, “Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma”, Pak J Med Sci, vol. 37, no. 1, Dec. 2020.